What is BioScience Health Innovations Days Payable?
BioScience Health InnovationsBHIC -0.73%45 Days Payable is 2.24 as of Mar. 2026, which is 59% below its 10-year median of 5.45. GuruFocus rates BHIC with a GF Score™ of 45/100 and a GF Value™ of $164.84 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 606 Healthcare Providers & Services companies, BioScience Health Innovations ranks worse than 99.5% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, BioScience Health Innovations's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioScience Health Innovations Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, BioScience Health Innovations's Days Payable distribution charts can be found below:
* The bar in red indicates where BioScience Health Innovations's Days Payable falls into.
BioScience Health Innovations Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioScience Health Innovations (BHIC) has a Days Payable of 2.24 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioScience Health Innovations and its competitors. This is 59% below median its historical median of 5.45. Over the past decade, BioScience Health Innovations' Days Payable has ranged from 1.04 to 16.01. According to the industry distribution chart, BioScience Health Innovations ranks #603 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 99.5%.
Is BioScience Health Innovations' Days Payable too high?
BioScience Health Innovations' current Days Payable of 2.24 is 59% below median its 10-year median of 5.45. Over the past 10 years, this metric has ranged from a low of 1.04 to a high of 16.01. The Healthcare Providers & Services industry median Days Payable is 58.21. BioScience Health Innovations' value of 2.24 is 96.2% below this industry median. Based on the distribution chart, BioScience Health Innovations ranks #603 out of 606 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, BioScience Health Innovations has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioScience Health Innovations' Days Payable compare to SHFH and PETS?
According to the Healthcare Providers & Services industry distribution chart, BioScience Health Innovations ranks #603 out of 606 companies for Days Payable. This places BioScience Health Innovations in the lower half of its industry. The industry median Days Payable is 58.21. BioScience Health Innovations' value of 2.24 is 96.2% below this benchmark. Historically, BioScience Health Innovations' own Days Payable has ranged from 1.04 to 16.01 over the past decade. While the company's 10-year median is 5.45 vs. the industry median of 58.21, BioScience Health Innovations has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioScience Health Innovations's current Days Payable of 2.24 is 96.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on BioScience Health Innovations and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioScience Health Innovations's current Days Payable is 2.24, which is 59% below median its own 10-year median of 5.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioScience Health Innovations stock overvalued right now?
Based on GuruFocus' analysis, BioScience Health Innovations (BHIC) is currently considered Possible Value Trap. The stock's GF Value™ is $164.84, compared to a current price of $4.07 — trading 97.5% below its estimated fair value. The current Days Payable is 2.24, which is 59% below median its 10-year median of 5.45 and 96.2% below the Healthcare Providers & Services industry median of 58.21. BioScience Health Innovations' overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For BioScience Health Innovations (BHIC), the current Days Payable is 2.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioScience Health Innovations (BHIC) Overvalued in 2026?
Based on GuruFocus' analysis, BioScience Health Innovations stock appears to be undervalued.
The current stock price of $4.07 is trading 97.5% below its estimated GF Value™ of $164.84.
GuruFocus considers BioScience Health Innovations to be Possible Value Trap.
Key valuation signals for BHIC:
Days Payable: 2.24 (59% below median its 10-year median of 5.45)
GF Value™: $164.84 vs. price of $4.07 (97.5% below fair value)
Industry Position: 96.2% below the Healthcare Providers & Services median (#603 of 606)
No single metric tells the full story. See the BHIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioScience Health Innovations Business Description
BioScience Health Innovations Inc is engaged in full-scale operations as a distributor and generates revenue. The company's main business is to sell clinically tested, affordably priced products to naturally battle the onslaught of bacteria and viruses through online sales and various other distribution channels. The company develops, manufactures, and distributes science-backed nutritional supplements and delivery systems targeting cellular health, mitochondrial optimization, hormonal balance, and longevity.
45GF Score
Get the complete analysis for BHIC
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHIC has been successfully added to your 
